Projects per year
Fingerprint
Dive into the research topics where Amit K. Verma is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 15 Finished
-
Diversity-focused Montefiore Einstein Clinical Oncology Training Program in the Bronx
Verma, A. K. (PI) & Saenger, Y. M. (CoPI)
4/1/23 → 3/31/24
Project: Research project
-
Therapeutic targeting of IRAK4 in MDS
Verma, A. K. (PI) & Starczynowski, D. T. (CoPI)
9/2/22 → 7/31/23
Project: Research project
-
STAT3 inhibition as a therapeutic strategy against MDS stem cells
Verma, A. K. (PI) & Steidl, U. G. (CoPI)
National Heart, Lung, and Blood Institute
7/23/19 → 6/30/23
Project: Research project
-
Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
Verma, A. K. (PI)
1/1/19 → 6/30/20
Project: Research project
-
Therapeutic targeting of MDS stem cells
Steidl, U. G. (PI) & Verma, A. K. (CoPI)
8/20/18 → 6/30/22
Project: Research project
-
A blueprint for pursuing therapeutic interventions and early phase clinical trials in clonal haematopoiesis
Haque, T., Shastri, A., Desai, P., Xie, Z., Hammond, D., King, Z., Kishtagari, A., Madanat, Y. F., Abaza, Y., Silver, A. J., Singh, A., Borate, U. M., Heimlich, J. B., Slosky, D. A., Bolton, K. L., Patnaik, M. S., Bick, A. G., Verma, A. K., Jaiswal, S. & Steensma, D. P. & 1 others, , Feb 2025, In: British Journal of Haematology. 206, 2, p. 416-427 12 p.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations -
A germline FLT3 variant in aplastic anemia
Amaeshi, L. C., Sofianidi, A. A., Shastri, A., Goldfinger, M., Konopleva, M., Verma, A. K., Chaitowitz, M. & Mantzaris, I., Dec 2025, In: Biomarker Research. 13, 1, 4.Research output: Contribution to journal › Letter › peer-review
Open Access -
Cigarette smoking is associated with worse prognosis in myelodysplastic syndromes and hematopoietic alterations in murine models
Verma, T., Sahu, S., Pradhan, K., Aggarwal, R. K., Gordon-Mitchell, S., Jasra, S., Dehghani, S. S., Zhang, H., Spodek, M., Mantzaris, I., Konopleva, M., Goldfinger, M., Verma, A. K., Hosgood, D., Verma, D., Shastri, A. & Zou, Y., 2025, (Accepted/In press) In: Leukemia and Lymphoma.Research output: Contribution to journal › Letter › peer-review
-
Inter-racial genetic differences in myelofibrosis: a diverse inner-city center analysis
Kamel, J., Yan, J., Rockwell, B., Goldfinger, M., Feldman, E. J., Konopleva, M. Y., Mantzaris, I., Shastri, A., Kornblum, N., Gritsman, K., Sica, A., Shah, N., Cooper, D., Verma, A. & Goel, S., 2025, In: Leukemia and Lymphoma. 66, 2, p. 329-332 4 p.Research output: Contribution to journal › Letter › peer-review
-
Single-cell analysis of oncolytic virotherapy in adult T-cell leukemia/lymphoma
An, J., Hu, E., Shi, Y., Fang, Y., Liu, N., Liu, Q., Wang, Q., Wang, Y., He, W., Wang, A., Song, Y., Shan, J., Zhang, J., Zou, Y., Cheng, H., Kabarriti, R., Cai, W., Verma, A., Sica, R. A. & Deng, W. & 1 others, , Mar 25 2025, In: Journal for ImmunoTherapy of Cancer. 13, 3, e011265.Research output: Contribution to journal › Article › peer-review